FLT3-ITD rarely occurs alone and most frequently coincides with mutations in nucleophosmin (NPM1) with many FLT3-ITD+/NPM1+ AML patients eventually relapsing [1]. This evidence concerns the gene NPM1 and acute myeloid leukemia.